Systemic inflammation as a therapeutic target in acute ischemic stroke

Area of Science:

• Neuroscience
• Immunology
• Cardiovascular Medicine

Background:

• Acute ischemic stroke is accompanied by systemic inflammation, which is linked to poor outcomes.
• Elevated inflammatory markers like IL-6 and C-reactive protein correlate with worse functional recovery and higher mortality.
• Animal studies confirm a causal link between systemic inflammation and ischemic brain injury.

Purpose of the Study:

• To review the relationship between systemic inflammation and cerebral ischemia.
• To discuss the impact of systemic inflammation on stroke prognosis.
• To explore potential therapeutic strategies targeting inflammation in stroke patients.

Main Methods:

• Literature review of studies investigating systemic inflammation in acute ischemic stroke.
• Analysis of mechanisms linking systemic inflammation to adverse stroke outcomes.
• Evaluation of therapeutic targets for modulating systemic inflammation in stroke.

Main Results:

• Systemic inflammation exacerbates ischemic brain damage through mechanisms like increased neutrophil infiltration and blood-brain barrier disruption.
• Inflammation contributes to impaired reperfusion, platelet activation, and microvascular coagulation.
• Targeting systemic inflammation presents promising therapeutic avenues for stroke management.

Conclusions:

• Systemic inflammation is a critical factor influencing stroke outcomes.
• Therapeutic strategies aimed at reducing systemic inflammation, such as IL-6 inhibition or enhancing anti-inflammatory responses, warrant further investigation.
• Modulating inflammatory pathways offers a potential approach to improve prognosis in acute ischemic stroke patients.